Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components

The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with each of the same components dual combinations in patients with moderate to severe hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stafylas, Panagiotis, Kourlaba, Georgia, Hatzikou, Magda, Georgiopoulos, Dimitrios, Sarafidis, Pantelis, Maniadakis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474457/
https://www.ncbi.nlm.nih.gov/pubmed/26097434
http://dx.doi.org/10.1186/s12962-015-0036-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474457/
https://www.ncbi.nlm.nih.gov/pubmed/26097434
http://dx.doi.org/10.1186/s12962-015-0036-x

Ejemplares similares